Skip to main content

Bereaved Widow files a Viagra Lawsuit

Bereaved Widow files a Viagra Lawsuit

Bereaved Widow files a Viagra Lawsuit

Introduction

Pfizer, Inc., has one more Viagra lawsuit filed against it by a bereaved widow who claims that Viagra was responsible for the development of her husband’s melanoma diagnosis and death. Owing to the growing number of lawsuits filed against the manufacturer of Viagra, the cases were centralized in 2016 as MDL No. 2691 (In Re: Viagra, Sildenafil Citrate, Products Liability Litigation), before Judge Richard Seeborg, in the Northern District of California, and comprise more than 500 lawsuits. Bellwether trials are set to begin in 2019. Allegations include that Pfizer failed to adequately warn the public and the medical community about the risk of skin cancer linked with Viagra, defective design, gross negligence, and fraudulent misrepresentation and concealment.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!